Aurelie Mallinger
London, ENG SM25NG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Mediator Kinase Inhibitor Selectivity and Activity in Colorectal Cancer.
Journal: ACS chemical biology
Published: July 02, 2025
Discovery of highly potent heme-displacing IDO1 inhibitors based on a spirofused bicyclic scaffold.
Journal: Bioorganic & medicinal chemistry letters
Published: October 14, 2020
Evaluation of APOBEC3B Recognition Motifs by NMR Reveals Preferred Substrates.
Journal: ACS chemical biology
Published: August 22, 2018
Inhibitors of cyclin-dependent kinases as cancer therapeutics.
Journal: Pharmacology & therapeutics
Published: February 09, 2017
Structure-Based Optimization of Potent, Selective, and Orally Bioavailable CDK8 Inhibitors Discovered by High-Throughput Screening.
Journal: Journal of medicinal chemistry
Published: August 05, 2016
Discovery of Potent, Selective, and Orally Bioavailable Small-Molecule Modulators of the Mediator Complex-Associated Kinases CDK8 and CDK19.
Journal: Journal of medicinal chemistry
Published: January 23, 2016
2,8-Disubstituted-1,6-Naphthyridines and 4,6-Disubstituted-Isoquinolines with Potent, Selective Affinity for CDK8/19.
Journal: ACS medicinal chemistry letters
Published: January 14, 2016
Discovery of potent and selective CDK8 inhibitors from an HSP90 pharmacophore.
Journal: Bioorganic & medicinal chemistry letters
Published: December 22, 2015
A selective chemical probe for exploring the role of CDK8 and CDK19 in human disease.
Journal: Nature chemical biology
Published: April 08, 2015
Discovery of potent, orally bioavailable, small-molecule inhibitors of WNT signaling from a cell-based pathway screen.
Journal: Journal of medicinal chemistry
Published: February 14, 2015
Showing 1-11 of 11
Last Updated: 09/26/2026